Date: 2015-04-15
Type of information: Collaboration agreement
Compound:
Company: Iris Pharma (France) Oculos Clinical Research (USA - FL)
Therapeutic area: Ophtalmological diseases - Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On April 15, 2015, Iris Pharma, a European ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug/device development services, and Oculos Clinical Research, a US full-service CRO specializing in the therapeutic area of ophthalmology, announced a strategic alliance between the Companies. Both companies have a common goal of providing high quality drug and device development services to their clients, from drug formulation through all phases of clinical trials in all ocular pathologies, including glaucoma, dry eye, anti-inflammatory and age-related macular degeneration.
Financial terms:
Latest news:
